양전자 방출 단층촬영(PET) 스캔 시장 : 시장 규모, 점유율 , 성장률, 산업 분석, 유형별, 용도별, 지역별 고찰 및 예측(2026-2034년)

Growth Factors of positron emission tomography (PET) scan Market

The global positron emission tomography (PET) scan market is witnessing steady growth due to the increasing burden of chronic diseases, rising demand for early and accurate diagnostics, and continuous advancements in imaging technologies. Positron emission tomography is a nuclear imaging technique that enables visualization of metabolic and physiological activities within the body, making it highly valuable for oncology, cardiology, and neurology applications.

In 2025, the global PET scan market size was valued at USD 18.71 billion. The market is projected to grow from USD 19.46 billion in 2026 to USD 29.67 billion by 2034, registering a CAGR of 5.41% during the forecast period (2026-2034). North America dominated the global market with a 52.38% market share in 2025, supported by advanced healthcare infrastructure, strong reimbursement frameworks, and widespread adoption of hybrid imaging systems.

COVID-19 Impact

The COVID-19 pandemic had a negative impact on the PET scan market due to lockdowns and the postponement of elective and non-emergency imaging procedures. Nuclear medicine services, including PET scans, experienced a decline in procedure volumes during 2020. However, since 2021, the resumption of diagnostic services and improved patient outcomes have supported market recovery. The growing importance of PET imaging in oncology and neurology has enabled the market to regain momentum and maintain steady growth during the forecast period.

Market Trends

Increasing Adoption of Hybrid Imaging Systems

One of the key trends shaping the PET scan market is the growing adoption of hybrid imaging systems such as PET/CT and PET/MRI. These systems combine functional and anatomical imaging, enhancing diagnostic accuracy, treatment planning, and disease monitoring. Guidelines published by the European Association of Nuclear Medicine (EANM) in 2023 have further supported the integration of PET/MRI into routine clinical practice.

Advancements in Radiotracer Development and AI Integration

Continuous advancements in radiotracer development are improving the detection and monitoring of cancers, neurological, and cardiovascular disorders. Additionally, the integration of artificial intelligence and machine learning is enhancing image reconstruction, reducing scan time, and improving workflow efficiency, thereby increasing PET scan adoption across healthcare facilities.

Market Growth Drivers

Rising Prevalence of Chronic Diseases

The rising incidence of cancer, neurological disorders, and cardiovascular diseases is a major driver of PET scan demand. PET imaging plays a critical role in early detection, disease staging, and treatment monitoring. According to WHO estimates, neurological disorders such as Parkinson's disease and Alzheimer's disease continue to rise globally, boosting demand for advanced diagnostic imaging.

Growing Demand for Early and Accurate Diagnosis

Government initiatives, increased healthcare spending, and investments in diagnostic infrastructure are driving demand for early and precise diagnostic tools. PET scans provide high sensitivity and specificity, making them an essential component of modern diagnostic pathways.

Restraining Factors

Despite favorable growth prospects, the market faces challenges due to high equipment and procedure costs, limited availability of radiopharmaceuticals, and restricted reimbursement policies in emerging countries. Additionally, the shortage of skilled professionals capable of operating advanced imaging systems remains a key constraint, particularly in developing regions.

Segmentation Analysis

By Indication

The oncology segment dominated the market with a 66.93% share in 2026, driven by the rising global cancer burden and increasing use of PET scans for diagnosis and treatment monitoring. Neurology and cardiology segments also hold significant shares due to increasing prevalence of neurological and cardiovascular disorders.

By Source of Payment

The public reimbursement segment accounted for a major share of 84.26% in 2026, supported by government healthcare funding and expanded reimbursement for PET imaging procedures in developed economies.

By Service Provider

Hospitals led the market with a 65.34% share in 2026, owing to advanced infrastructure, high patient volumes, and availability of hybrid imaging systems. Diagnostic centers are expected to witness steady growth due to increasing standalone imaging facilities.

Regional Insights

• North America: Generated USD 10.2 billion in 2026, with the U.S. market projected to reach USD 10.11 billion by 2026
• Europe: Growth supported by rising chronic disease prevalence and expanding PET scanner installations
• Asia Pacific: Expected to register the highest CAGR due to healthcare investments and aging population
• Latin America & Middle East & Africa: Moderate growth due to limited reimbursement and infrastructure

Key Industry Players

Major players include RadNet, Inc., Sonic Healthcare Limited, Akumin Inc., Alliance Medical Limited, Apex Radiology, InHealth Group, and Novant Health. Strategic partnerships, AI integration, and expansion of imaging networks remain key competitive strategies.

Conclusion

The global positron emission tomography (PET) scan market is set for steady expansion, growing from USD 18.71 billion in 2025 to USD 29.67 billion by 2034. Rising prevalence of chronic diseases, increasing demand for early and accurate diagnostics, and technological advancements such as hybrid imaging and artificial intelligence are driving market growth. Although high costs, reimbursement limitations, and workforce shortages pose challenges, continued investments in healthcare infrastructure and innovation are expected to support sustained market development over the forecast period.

Segmentation By Indication,Source of Payment, Service Provider, and Region

By Indication * Oncology

• Cardiology
• Neurology
• Others

By Source of Payment * Public

• Private Health Insurance/Out-of-pocket

By Service Provider * Hospitals

• Diagnostic Centers
• Others

By Region * North America (By Indication, By Source of Payment, By Service Provider, By Country)

• U.S.
• Canada
• Europe (By Indication, By Source of Payment, By Service Provider, By Country/Sub-Region)
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Scandinavia
  • Rest of Europe
• Asia Pacific (By Indication, By Source of Payment, By Service Provider, By Country/Sub-Region)
  • Japan
  • China
  • India
  • Australia
  • Southeast Asia
  • Rest of Asia Pacific
• Latin America (By Indication, By Source of Payment, By Service Provider, By Country/Sub-Region)
  • Brazil
  • Mexico
  • Rest of Latin America
• Middle East & Africa (By Indication, By Source of Payment, By Service Providers, By Country/Sub-Region)
  • GCC
  • South Africa
  • Rest of Middle East & Africa

Table of Content

1. Introduction

• 1.1. Research Scope
• 1.2. Market Segmentation
• 1.3. Research Methodology
• 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Market Trends

4. Key Insights

• 4.1. Number of PET Scans, Key Countries/ Region, 2025
• 4.2. Regulatory Scenario, By Key Countries/ Region
• 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships, Launches, etc.)
• 4.4. Impact of COVID-19 in the Market

5. Global Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

• 5.1. Market Analysis, Insights and Forecast - By Indication
  • 5.1.1. Oncology
  • 5.1.2. Cardiology
  • 5.1.3. Neurology
  • 5.1.4. Others
• 5.2. Market Analysis, Insights and Forecast - By Source of Payment
  • 5.2.1. Public
  • 5.2.2. Private Health Insurance/Out-of-pocket
• 5.3. Market Analysis, Insights and Forecast - By Service Provider
  • 5.3.1. Hospitals
  • 5.3.2. Diagnostic Centers
  • 5.3.3. Others
• 5.4. Market Analysis, Insights and Forecast - By Region
  • 5.4.1. North America
  • 5.4.2. Europe
  • 5.4.3. Asia Pacific
  • 5.4.4. Latin America
  • 5.4.5. Middle East & Africa

6. North America Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

• 6.1. Market Analysis, Insights and Forecast - By Indication
  • 6.1.1. Oncology
  • 6.1.2. Cardiology
  • 6.1.3. Neurology
  • 6.1.4. Others
• 6.2. Market Analysis, Insights and Forecast - By Source of Payment
  • 6.2.1. Public
  • 6.2.2. Private Health Insurance/Out-of-pocket
• 6.3. Market Analysis, Insights and Forecast - By Service Provider
  • 6.3.1. Hospitals
  • 6.3.2. Diagnostic Centers
  • 6.3.3. Others
• 6.4. Market Analysis, Insights and Forecast - By Country
  • 6.4.1. U.S.
  • 6.4.2. Canada

7. Europe Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

• 7.1. Market Analysis, Insights and Forecast - By Indication
  • 7.1.1. Oncology
  • 7.1.2. Cardiology
  • 7.1.3. Neurology
  • 7.1.4. Others
• 7.2. Market Analysis, Insights and Forecast - By Source of Payment
  • 7.2.1. Public
  • 7.2.2. Private Health Insurance/Out-of-pocket
• 7.3. Market Analysis, Insights and Forecast - By Service Provider
  • 7.3.1. Hospitals
  • 7.3.2. Diagnostic Centers
  • 7.3.3. Others
• 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 7.4.1. Germany
  • 7.4.2. U.K.
  • 7.4.3. France
  • 7.4.4. Spain
  • 7.4.5. Italy
  • 7.4.6. Scandinavia
  • 7.4.7. Rest of Europe

8. Asia Pacific Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

• 8.1. Market Analysis, Insights and Forecast - By Indication
  • 8.1.1. Oncology
  • 8.1.2. Cardiology
  • 8.1.3. Neurology
  • 8.1.4. Others
• 8.2. Market Analysis, Insights and Forecast - By Source of Payment
  • 8.2.1. Public
  • 8.2.2. Private Health Insurance/Out-of-pocket
• 8.3. Market Analysis, Insights and Forecast - By Service Provider
  • 8.3.1. Hospitals
  • 8.3.2. Diagnostic Centers
  • 8.3.3. Others
• 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 8.4.1. Japan
  • 8.4.2. China
  • 8.4.3. India
  • 8.4.4. Australia
  • 8.4.5. Southeast Asia
  • 8.4.6. Rest of Asia Pacific

9. Latin America Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

• 9.1. Market Analysis, Insights and Forecast - By Indication
  • 9.1.1. Oncology
  • 9.1.2. Cardiology
  • 9.1.3. Neurology
  • 9.1.4. Others
• 9.2. Market Analysis, Insights and Forecast - By Source of Payment
  • 9.2.1. Public
  • 9.2.2. Private Health Insurance/Out-of-pocket
• 9.3. Market Analysis, Insights and Forecast - By Service Provider
  • 9.3.1. Hospitals
  • 9.3.2. Diagnostic Centers
  • 9.3.3. Others
• 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 9.4.1. Brazil
  • 9.4.2. Mexico
  • 9.4.3. Rest of Latin America

10. Middle East & Africa Positron Emission Tomography Scan Market Analysis, Insights and Forecast, 2021-2034

• 10.1. Market Analysis, Insights and Forecast - By Indication
  • 10.1.1. Oncology
  • 10.1.2. Cardiology
  • 10.1.3. Neurology
  • 10.1.4. Others
• 10.2. Market Analysis, Insights and Forecast - By Source of Payment
  • 10.2.1. Public
  • 10.2.2. Private Health Insurance/Out-of-pocket
• 10.3. Market Analysis, Insights and Forecast - By Service Provider
  • 10.3.1. Hospitals
  • 10.3.2. Diagnostic Centers
  • 10.3.3. Others
• 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
  • 10.4.1. GCC
  • 10.4.2. South Africa
  • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

• 11.1. Global Market Share Analysis (2025)
• 11.2. Company Profiles (Overview, Services, SWOT Analysis, Recent Developments, Strategies, financials (Based on Availability))
  • 11.2.1. RadNet, Inc.
  • 11.2.2. Sonic Healthcare Limited
  • 11.2.3. Akumin Inc.
  • 11.2.4. Apex Radiology
  • 11.2.5. Alliance Medical Limited
  • 11.2.6. Novant Health
  • 11.2.7. InHealth Group
  • 11.2.8. Dignity Health
  • 11.2.9. Concord Medical